The early clinical manifestations of hepatocellular carcinoma (HCC) are insidious and atypical
and how to perform precise diagnosis in the early stage of HCC is still a great challenge. Contrast-enhanced ultrasound (CEUS) is widely used in the diagnosis and efficacy evaluation of HCC. The advent of radiomics has greatly promoted the development of precision medicine
and the combination of the two is expected to become a more promising monitoring tool in HCC diagnosis. This review described the current status of CEUS-based radiomics in the diagnosis of HCC
as well as the directions and challenges of future research.